Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 13Neoplasms 12Brain Neoplasms 6Prostatic Neoplasms 5Neoplasm Metastasis 4Lung Neoplasms 4Sarcoma 3Multiple Myeloma 3Melanoma 3Glioblastoma 3Gastrointestinal Neoplasms 3Esophageal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Uterine Cervical Neoplasms 2Thymus Neoplasms 2Stomach Neoplasms 2Sarcoma, Synovial 2Rectal Neoplasms 2Pain 2Ovarian Neoplasms 2Oligodendroglioma 2Neuroendocrine Tumors 2Nasopharyngeal Carcinoma 2Mesothelioma 2Liposarcoma 2Hematologic Neoplasms 2Head and Neck Neoplasms 2Glioma 2Fatigue 2Colorectal Neoplasms 2

Interventions

Exercise 6Transcranial Direct Current Stimulation 4Neuropsychological Tests 4Walking 3Memantine 3Tablets 2Standard of Care 2Patient Reported Outcome Measures 2Methods 2Electroencephalography 2Drug Therapy 2Donepezil 2Cognitive Behavioral Therapy 2mazdutide 1lithium sulfate 1lime 1fasudil 1enzalutamide 1blueberry extract 1beta Carotene 1acetaminophen, aspirin, caffeine drug combination 1XENP 1595 1Vitamin E 1Vitamin D 1Ultraviolet Therapy 1Transcranial Magnetic Stimulation 1Time 1Therapeutics 1Tai Ji 1Surveys and Questionnaires 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cognitive Dysfunction × Quality of Life × Clear all
NCT04708548 2023-05-15

Long Term Implications of Rare Brain Tumours'

University of Leeds

Completed
267 enrolled
CNS

Oligodendroglioma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡